Clinical Trials Browser

OTHER_GOV × Gefitinib × Clear all

NCT03457337 2020-07-10

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Phase 2 Unknown

Advanced NSCLC With EGFR Mutation

NCT03486496 2018-04-03

Geber

Phase 2 Unknown

Adenocarcinoma of Lung

NCT00452244 2017-08-25

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Completed

Lung Neoplasms

NCT01405846 2016-08-19

TIDAL1

Phase 2 Terminated

Head & NeckThoracic

Head and Neck Neoplasms, Lung Neoplasms

NCT02740894 2016-04-15

Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

Is Targeted Therapy Increasing Survival Inoperable Nonsmall Cell Lung Cancer With Spinal Metastasis ?

NCT01502202 2012-06-20

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Phase 2 Unknown

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00455936 2010-10-25

First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker

Phase 3 Completed

Adenocarcinoma, Lung Neoplasms

NCT01037998 2009-12-23

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

Phase 2 Completed

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung